A sweetener marketed as a healthier alternative to sugar may be doing something far more serious than simply satisfying a sweet tooth — it may be interfering with the very cells that protect your brain.
New laboratory research has found that erythritol, a sugar alcohol widely used in low-calorie drinks, protein bars, and “better-for-you” snacks, can alter the behavior of the cells lining the brain’s smallest blood vessels. The findings raise questions that go well beyond typical food safety debates and touch on something most people never think to ask: what is the sweetener in my drink actually doing to my brain?
The research is early-stage, and scientists are careful to note it does not prove harm in living humans. But the biological pathway it identifies is specific, measurable, and worth understanding before you reach for another erythritol-sweetened product.
What Erythritol Is and Why So Many People Are Consuming It
Erythritol belongs to a family of compounds called sugar alcohols. It occurs naturally in small amounts in some fruits and fermented foods, but the version found in commercial products is typically manufactured through an industrial fermentation process. It has roughly 70 percent of the sweetness of sugar, almost no calories, and does not spike blood glucose the way regular sugar does — which is why it became a go-to ingredient for keto products, diabetic-friendly foods, and anyone trying to cut back on sugar without giving up sweetness.
You will find it listed on the labels of protein bars, flavored sparkling waters, sugar-free chocolates, meal replacement shakes, and a growing range of baked goods. Its popularity has surged alongside the broader low-sugar movement, and it is now one of the most commonly consumed non-caloric sweeteners on the market.
For most consumers, erythritol has felt like a safe bet — approved by regulators, naturally derived in origin, and free from the aftertaste controversies that have plagued other sweeteners. That reassuring reputation is now being examined more carefully.
What the New Research Actually Found
The study was conducted by Professor Christopher A. DeSouza at the University of Colorado Boulder. His team worked with cultured human brain microvascular endothelial cells — the specialized cells that line the inner walls of the brain’s tiny blood vessels and form a critical part of the blood-brain barrier.
That barrier is one of the body’s most important protective systems. It controls what substances can pass from the bloodstream into brain tissue, filtering out toxins, pathogens, and other harmful agents while allowing nutrients and oxygen through. When those barrier cells malfunction, the consequences can be serious.
After exposing the cells to erythritol in amounts comparable to what a person might consume from a single sweetened drink, the research team documented clear signs of cellular dysfunction. Rather than maintaining normal, balanced signaling, the treated cells shifted toward a state associated with constriction and reduced protective capacity. Specifically, the researchers observed disruptions in how those cells regulate blood flow and dissolve clots — two functions that are directly relevant to stroke risk.
That is the part of this story that most reports gloss over. This is not a vague association between a food additive and a health outcome. The research points to a specific biological mechanism: erythritol appears to alter endothelial cell behavior in ways that could, in theory, reduce the brain’s ability to maintain healthy circulation and respond to clot formation.
What the Science Can and Cannot Tell Us Right Now
| What the Research Confirms | What Remains Uncertain |
|---|---|
| Erythritol exposure altered brain microvascular endothelial cells in a lab setting | Whether the same effects occur in living humans |
| Cellular changes were observed after short-term exposure at single-drink equivalent amounts | What level of long-term consumption would be required to cause harm |
| The disruption affected blood flow regulation and clot-dissolving functions | Whether the blood-brain barrier is compromised in the same way outside a lab |
| A direct biological pathway linking erythritol to stroke-related mechanisms was identified | Whether current regulatory guidelines need to be revised based on this data |
The researchers themselves acknowledged that early cellular findings do not prove harm in living people. Laboratory studies on cultured cells are a starting point — an important one — but they are not the same as clinical trials or population-wide studies. What this research does is establish a focused biological pathway that, in the scientists’ own framing, demands closer scrutiny.
Why This Matters More Than Typical Food Additive Stories
Most food additive controversies center on long-term cancer risk or digestive side effects — concerns that feel abstract and distant. This one is different. The brain’s protective barrier is not a background system. It is actively working every moment to keep harmful substances out of your neural tissue.
When endothelial cells in the brain’s blood vessels shift toward constriction and lose some of their protective function — even temporarily — the downstream risks are not trivial. Blood clot regulation and vessel constriction are two of the core factors involved in stroke, which remains one of the leading causes of death and disability worldwide.
Erythritol is not a trace ingredient hiding in a rarely consumed product. It is a primary sweetener in a wide and growing category of foods actively marketed as health-conscious choices. That is what makes the timing of this research particularly significant.
What Happens Next in the Research
Based on The next logical steps in this line of research would typically involve animal studies and eventually human clinical trials to determine whether the cellular effects observed in the lab translate into measurable health outcomes in people who regularly consume erythritol.
Scientists involved in this field have noted that these early cellular changes establish a clear biological rationale for further investigation. Whether that leads to revised consumption guidelines, new labeling requirements, or changes in how the food industry uses erythritol remains to be seen — and has not yet been confirmed by regulatory bodies.
For now, consumers who regularly rely on erythritol-sweetened products have reason to follow this research closely. The sweetener is not being pulled from shelves, and no regulatory action has been announced. But the science is asking questions that the food industry will eventually need to answer.
Frequently Asked Questions
What is erythritol and where is it commonly found?
Erythritol is a sugar alcohol used as a low-calorie sweetener in products like flavored drinks, protein bars, and sugar-free snacks. It is popular in keto and diabetic-friendly food products.
What did the University of Colorado Boulder study find?
Professor Christopher A. DeSouza and his team found that erythritol exposure altered the behavior of human brain microvascular endothelial cells, disrupting blood flow regulation and clot-dissolving functions in ways linked to stroke risk.
Does this study prove that erythritol causes strokes?
No. The research was conducted on cultured cells in a laboratory setting, and the scientists explicitly stated that these early findings do not prove harm in living people. They do, however, identify a specific biological pathway that warrants further investigation.
How much erythritol was used in the experiment?
The cells were exposed to amounts comparable to what a person might consume from a single sweetened drink, according to the research described in
Should people stop consuming erythritol based on this research?
No regulatory body has issued guidance advising consumers to avoid erythritol based on this study. The findings are preliminary and further research is needed before any official recommendations would be expected.
Will there be follow-up studies?
Leave a Reply